EpidStrategies’ Naomi Sacks is at ISPOR
Dr. Sacks is a co-author on four poster presentations at the annual meeting of ISPOR (The Professional Society for Health Economics and Outcomes… read more
Latest News
Scientists from EpidStrategies are attending ISPOR 2023 in Boston!
Scientists from EpidStrategies are attending ISPOR 2023 in Boston! Please reach out and connect with us and meet the newest addition to our… read more
EpidStrategies Researchers Are Presenting at the 2023 Pediatric Academic Societies Meeting
EpidStrategies, a division of ToxStrategies LLC, is excited to announce that Mina Suh, Naimisha Movva, Xiaohui Jiang, Sue Pastula, Heidi Reichert, and Jon… read more
Systematic review article accepted for publication
A publication titled, “Benefit-Risk of Coffee Consumption and All-Cause Mortality: A Systematic Review and Disability Adjusted Life Year Analysis,” by ToxStrategies authors Candace… read more
EpidStrategies announces seven new publications of RSV research
Several EpidStrategies scientists are among the collaborating authors of seven new studies on respiratory syncytial virus (RSV) published in a special supplement to… read more
Congratulations to Dr. John Rogers on the RDTSS Scientific Achievement Award
The Reproductive and Developmental Toxicology Specialty Section of the Society of Toxicology recently awarded its Scientific Achievement Award to ToxStrategies Senior Consultant Dr…. read more
Assessment of per- and polyfluoroalkyl substances (PFAS)
Concerns about potential health risks associated with low-level exposures to PFAS, along with their widespread uses and reported detections in various environmental media… read more
Cross-discipline team publishes on Cr(VI) in air
A team of ToxStrategies and EpidStrategies scientists are authors on a manuscript being published in Regulatory Toxicology and Pharmacology. The study examines current… read more
New study looks at chemotherapy dose intensity
EpidStrategies scientists Dr. Jon Fryzek, Ms. Lauren Bylsma, and colleagues, have published a paper assessing one of the key elements of chemotherapy for… read more
EpidStrategies participating in European Hematology Association 2021
EpidStrategies, a division of ToxStrategies, Inc., is excited to be participating in the European Hematology Association Virtual Congress, which will be held virtually from… read more